key: cord-0709721-2d29r7wa
authors: Alexander, Marina R.; Brice, Aaron M.; van Vuren, Petrus Jansen; Rootes, Christina L.; Tribolet, Leon; Cowled, Christopher; Bean, Andrew G. D.; Stewart, Cameron R.
title: Ribosome-profiling reveals restricted post transcriptional expression of antiviral cytokines and transcription factors during SARS-CoV-2 infection
date: 2021-03-04
journal: bioRxiv
DOI: 10.1101/2021.03.03.433675
sha: d50ee9789b2fb3de3c41158a814f16cf894e0292
doc_id: 709721
cord_uid: 2d29r7wa

The global COVID-19 pandemic caused by SARS-CoV-2 has resulted in over 2.2 million deaths. Disease outcomes range from asymptomatic to severe with, so far, minimal genotypic change to the virus so understanding the host response is paramount. Transcriptomics has become incredibly important in understanding host-pathogen interactions; however, post-transcriptional regulation plays an important role in infection and immunity through translation and mRNA stability, allowing tight control over potent host responses by both the host and the invading virus. Here we apply ribosome profiling to assess post-transcriptional regulation of host genes during SARS-CoV-2 infection of a human lung epithelial cell line (Calu-3). We have identified numerous transcription factors (JUN, ZBTB20, ATF3, HIVEP2 and EGR1) as well as select antiviral cytokine genes, namely IFNB1, IFNL1,2 and 3, IL-6 and CCL5, that are restricted at the post-transcriptional level by SARS-CoV-2 infection and discuss the impact this would have on the host response to infection. This early phase restriction of antiviral transcripts in the lungs may allow high viral load and consequent immune dysregulation typically seen in SARS-CoV-2 infection.

Coronaviruses are enveloped positive sense RNA viruses with an exceptionally large genome encoding the structural proteins envelope (E), spike (S), membrane (M), and nucleocapsid (N), in addition to a plethora of non-structural and accessory proteins. Infections with endemic human coronaviruses (e.g. 229E, NL63, OC43, and HKU1) cause a mild common cold, however three novel coronaviruses have emerged from animal reservoirs in the 21 st century, SARS-CoV, MERS and SARS-CoV-2 causing a fatal respiratory syndrome in 34%, 15%, and 3% of cases, respectively with SARS-CoV-2 being the most infectious [1] . The current COVID-19 pandemic caused by SARS-CoV-2 emerged in China in December 2019 [2] and has since spread across the globe, causing more than 100 million confirmed cases and over 2 million deaths (https://covid19.who.int/ accessed February 2021).

SARS-CoV-2 is adept at evading innate immunity [3] , the naïve host's primary defense against a newly emerged coronavirus. It does this using numerous structural and nonstructural proteins that inhibit interferon (IFN) production and function. Through blocking IFN, viral replication can proceed unchecked. In addition to antiviral functions, circulating IFN alerts the host to viral infection with symptoms such as fever, pain and fatigue [4] . This capacity for stealth replication in the absence of symptoms allows asymptomatic transmission [5] , making it particularly difficult to control from a public health perspective. Understanding the molecular mechanics of immune evasion strategies employed by SARS-CoV-2 will allow us to develop more effective diagnostics, therapeutics, and host prognostic indicators.

RNA sequencing (RNA-seq) enables discovery of molecular pathways involved in SARS-CoV-2 infection. RNA-seq of nasopharyngeal swabs from infected individuals revealed up-regulation of antiviral factors OAS1-3 and IFIT1-3 as well as chemokines like IP-10, the latter of which showed muted expression in older individuals [6] . Added to this, transcriptional profiles in SARS-CoV-2 infected cell, animal and patient serum samples revealed low levels of type I and III interferons but high levels of TNF, IL-6, RANTES and CCL20 compared to influenza A infection, indicating differences in the immune responses to SARS-CoV-2 compared to another respiratory virus [7] . These studies have provided a greater insight into potential mechanisms underpinning COVID-19 immunopathogenesis. However, they do not capture post-transcriptional regulatory mechanisms, many of which control the initiation, magnitude, duration, and resolution of the innate immune response [8] or allow the virus to restrict host gene expression [9] .

Here we have used ribosome profiling to assess post-transcriptional regulation of host gene expression during SARS-CoV-2 infection. We found restricted translation of type I and III IFNs 24 hours post infection as well as numerous transcription factors and antiviral cytokines. This data provides a set of genes likely responsible for the delayed antiviral responses seen in SARS-type coronavirus infections strengthening development of molecular-based strategies to combat this devastating pandemic.

Of the multiple organs that SARS-CoV-2 infects, viral load is highest in the lungs, and infection of this organ is a significant driver of pathogenesis [10] . We therefore chose a lung epithelial cell line known to be productively infected with SARS-CoV-2 to investigate host responses to infection. Calu-3 cells are a human immortalized cell line derived from lung adenocarcinoma which express sufficient levels of ACE2 to allow SARS-Cov-2 entry. We found SARS-CoV-2 infectious titres peaked 24 hours post infection in Calu-3 cells ( Figure 1A ) as per other studies [11] . Both SARS-CoV-2 intracellular genomic RNA ( Figure 1B ) and N protein ( Figure 1C ) followed similar kinetics with peak viral load post 24 hours infection. Immunofluorescence staining of SARS-CoV-2 N-protein over a time-course from 1-48hrs showed infection of more than 50% of cells after 24 hours ( Figure 1D ).

Having developed an infection model in Calu-3 cells, we proceeded to capture transcriptional and post-transcriptional changes in gene expression at 24 hours post SARS-CoV-2 infection using a method deemed suitable for high containment infections [12] . Cells were snap frozen in liquid nitrogen to lock ribosomes onto their associated mRNA, avoiding artifacts introduced by translation inhibitors like cycloheximide [13] . Both total RNA and RNA protected by protein from micrococcal nuclease (MNase) digest were purified. The latter, named herein as ribosome footprints were further purified to contain fragments between 25 and 35nt which spans the possible 80S ribosomal footprint on actively translated mRNAs ( Figure   A1 ). Approximately 30 million reads were obtained from next generation sequencing of the total mRNA libraries, while more than 50 million reads were obtained from the MNase-digested small RNA libraries.

We first analysed reads obtained from total RNA representing the transcriptome. 11504 genes passed the threshold of >1 counts per million in at least three samples and were analysed for differential expression by comparing triplicate mock and SARS-CoV-2-infected samples. There were 2.5 times more up-regulated than down-regulated genes (166 versus 63, Figure 2A ) using a log2 fold change cutoff of 1 and p-value cut-off of 0.05. Upon inspection of the genes up-regulated by SARS-CoV-2 infection, many genes were previously annotated antiviral genes ( Figure   2A ). To confirm this, the 229 significantly altered genes were submitted to https://david.ncifcrf.gov/ for functional annotation clustering using the Uniprot keyword database. The top seven significantly enriched keywords are plotted in Figure 2B . Antiviral defence showed the highest fold enrichment and a pvalue <0.001. Other significantly enriched keywords included innate immunity, RNAbinding and transcription. Of the 134 Antiviral defence keywords, 27 were up-regulated by SARS-CoV-2 and are listed in Figure 2C . Many of these genes, including IFIT1, IFIT2, IFIT3, RSAD2, OASL, HERC5, DDX58 and MX2 were also upregulated in nasopharyngeal swabs of COVID19 patients [6] .

Next, we proceeded to analyse the reads generated from sequencing of sizeselected MNase-digested RNA to understand the translatome in SARS-CoV-2 infected cells. 50% of the reads (approximately 25 million reads) mapped to protein coding sequence in both mock and infected cells ( Figure 3A ), indicating close to 50% coverage of the 18 million nucleotides of coding sequence predicted in the human transcriptome [14] . This finding implies that sequencing depth was sufficient to make gene level inferences on differential ribosome density. More than 50% of reads mapped to the first 30 nucleotides of tRNAs mostly carrying the small neutral amino acid Glycine and some carrying the small to medium sized acidic amino acids, Glutamate and Aspartate (data not shown). These tRNA reads and the less abundant reads mapping to other non-coding RNA were filtered out and remaining reads mapped to different features of human protein coding genes. Most of these filtered reads (60%) mapped to within the CDS ( Figure 3B ). The 3'UTR and 5'UTR had 20%

and 7% of the reads respectively no significant difference between mock and infected cells was observed. Annotated start and stop codons were present in 2% and 6% of the reads, respectively with no difference between mock and infected. When highresolution metagene analysis of transcript coverage was performed, a gradual increase in coverage was seen leading up the start codon, whereby coverage increased 8-fold to a peak around 30nt consistent with ribosomes initiating at the start codon ( Figure 3C and D).

Eukaryotic 80S ribosome footprints are ~28-30 nucleotides in length [15] . To confirm that CDS-mapped reads were bona fide ribosome footprints, read-lengths were calculated for reads mapping to the CDS and the 5'UTR region as 80S ribosomes scan this region to find the start codon [16] . Read-length distributions were summarised across all genes. Density peaked at 28-30 nucleotides in coding sequence in both mock and infected cells indicative of bona-fide ribosome footprints ( Figure 3E ). Read-lengths higher than 30 nucleotides showed an exponential shortening towards 40 nucleotides suggesting single nucleotide degradation, while those shorter than 30 nucleotides were staggered suggestive of footprints derived from smaller non-ribosomal RNA binding proteins. In the 5' UTR read lengths also peaked at 30 nucleotides indicative of translation in the 5' leader as documented elsewhere [17] but at >6-fold lower density compared to the CDS mapped reads ( Figure 3E ).

There was no significant difference in 5' UTR ribosome occupancy between mock and infected cells apart from greater variance between replicates in the infected samples. . Of note is that many genes seen upregulated at the whole transcript level were not seen to be differentially expressed when ribosome-associated RNA was sequenced.This transcriptome-only change contrasts with other stimulatory contexts where 9% of genes showed transcriptome-only upregulation and 85% of genes showed translationonly upregulation [18] .

We investigated this paucity of up-regulated genes further, using functional annotation clustering on the differential expression gene lists for RNA-seq versus Ribo-seq.

Using Uniprot keywords to classify genes, showed an absence of keywords 'Signal', Within the 'Innate immunity' annotation group, most genes upregulated by RNAseq were also upregulated by Ribo-seq, except for NLRC5, a negative regulator of NFKB and IFN-I signalling [19] , which was 2.2-fold and 6. Neither were Ribo-seq reads in the 3'UTR associated with discordance as both IL6

and IRF1 showed peaks >250 nucleotides downstream of the reference sequence stop codon. In summary, while transcript levels for genes like IL6, CCL5, IFNB1 and JUN were upregulated, these transcripts were not increased in their association with ribosomes suggesting a restriction in the antiviral response.

Differential expression analysis of Ribo-seq count data allowed us to examine the genes which up-regulated in ribosomal occupancy and is a closer approximation to protein output and phenotype than RNA-seq [20] . However, to understand the mechanism through which a restriction in ribosome occupancy occurs, we need to separate the two processes of transcription and translation. Translation efficiency considers the background mRNA levels. We utilized a method, Riborex, whereby RNA-seq count data obtained from matched biological samples is factored into a generalized linear model for the Ribo-seq counts to find genes with differential translational efficiency [21] .

Many transcription factors and secreted proteins, which encompass cytokines were found to have short half-lives in mouse embryonic stem cells [22] . To assist in explaining why some cytokines and transcription factors were sensitive to translation inhibition while others were not, we categorized genes based on their mRNA stability as documented by Sharova et al. [22] 6,878 genes with known mRNA half-lives and which passed the default threshold values for Riborex differential expression analysis are presented in Figure 6A . of downregulated genes contained no uORF and 1.8% containing at least one uORF, respectively were decreased in translation efficiency ( Figure 6C ). Across all genes the mean log2 fold change in translation efficiency was lower for those genes containing an uORF (one-way analysis of variance [ANOVA], p < 0.001; Figure 6D .

Since mRNAs predicted to contain at least one uORF are more likely to be decreased instead of increased in translation efficiency, uORFs are protective against translation inhibition by SARS-CoV-2 infection. To further explore this, we obtained a list of 68

homologous genes known to increase in translation during EIF2A phosphorylation (EIF2A-P) in mouse embryonic fibroblasts and contain an uORF in humans. We then compared them with significantly altered genes from our mock versus SARS-CoV-2 infected comparison of translation efficiency. We found no EIF2A-P enhanced genes in the genes upregulated in translation efficiency by SARS-CoV-2 infection ( Figure   6E ). Eighteen genes were downregulated in translation efficiency by SARS-CoV-2 but known to increase in the presence of EIF2A-P in mouse embryonic fibroblasts. This finding gives further weight to the hypothesis that downregulation of translation efficiency by SARS-CoV-2 is independent of EIF2A-P.

Largely driven by signaling molecules called interferons (IFNs), the innate immune system first recognizes non-self, pathogen-associated molecular patterns (PAMPs)

such as double stranded RNA through host proteins DDX58 (RIG-I) and toll-like SARS-CoV-2 is remarkably sensitive to type I IFN pre-treatment [11] , suggesting that limiting IFN production, rather than function is the main mechanism through which SARS-CoV-2 achieves high viral loads concomitant with delayed or absent symptoms.

Non-structural protein 1 (Nsp1) was found to be one of the most potent inhibitors of IFNB1 promoter induction of 26 viral proteins tested [27] . Nsp1 acts to inhibit host translation by blocking the mRNA entry tunnel on the 40S ribosome [28] . This interaction can also lead to endonucleolytic cleavage in the 5' UTR preventing the recruitment of more ribosomes to host mRNAs [29, 30] .

Studies in bronchial epithelial cells show posttranscriptional restriction of IFNL1/2, IFNB1, CCL5 and IL6 by SARS-CoV-1 and not Dhori virus, an orthomyxovirus known to also productively infect 2B4 cells [31] . Here we corroborate these findings in Calu3 cells using an unbiased genome-wide methodology showing that antiviral cytokines (IFNL1-3, IFNB1, CCL5, CXCL11 and IL6) are restricted in translation at 24 hours post infection. This is consistent with the delayed IFN response seen in COVID19 [32] . Importantly, in a mouse model of SARS-CoV, IFN was only detected in the lung after viral load had already peaked rendering this arm of innate immunity entirely ineffective [33] .

A host driven delay in IL6 protein production is unlikely because poly I:C treatment of Calu-3 cells results in a 2-12 fold increase in secreted IL-6 in just 4 hours, with the upper range dependent upon a Th1/17 cytokine environment [34] . IL6 is a significant driver of fever [35] , which was an initial symptom in 41% of 174 health care workers that tested positive for SARS-CoV-2 infection upon routine screening [36] . Delayed IL6 production could explain the relatively slow onset of symptoms in [41] . Post-transcriptional restriction of JUN could limit enhanceosome formation and IFN induction. Indeed, weak induction of IFNB1 mRNA was seen by SARS-CoV-2 in Calu-3 cells compared to Sendai virus [42] . ZBTB20 promotes Toll-like receptor innate immune responses by inhibiting transcription of IKBA [43] , decreased protein expression of ZBTB20 may therefore delay immune responses.

In contrast, ATF3 is anti-inflammatory, reducing IL6 and IL12B transcription as part of a negative feedback loop [44] . Restriction in ATF3 protein expression may contribute to un-controlled IL6 production in cells that overcome the translational block, either through competition with ever increasing amounts of IL6 mRNA [45] or through an increase in IL6 mRNA stability enacted by the balance of RNA binding proteins ZC3H12A (Regenase-1) and ARID5A [46] . The latter of which stabilizes IL6 and is negatively regulated by MAPK14 (p38 MAPK) to resolve inflammation [47] .

The increase in MAPK14 (p38 MAPK) signalling in aged tissues may contribute to uncontrolled IL6 production [48] . HIVEP2 may also be anti-inflammatory, acting as an NFKB inhibitor, enabling cell survival during memory T cell development [49] .

Whether HIVEP2 translational restriction contributes to immune dysregulation or enhances SARS-CoV-2 in infected airway epithelial cells is unclear. Assuming a closed loop model of translation facilitated by the eIF4G (5' cap) to poly(A)-binding protein (3' tail) interaction [58] , stabilized mRNAs are more likely to have ribosomes that re-initiate on the same mRNA, a process coined closed-loop assisted reinitation (CLAR) [59] . Mammalian ribosomes translate at approximately 6 seconds per amino acid [60] and must be spaced ~100 nucleotides apart [61] . We found that mRNAs containing at least one high-confidence uORF were more likely to be decreased in translation efficiency. Given that most genes preferentially Aldrich) for 30 mins at 37°C to generate ribosome-protected fragments (RPFs). Both digested and undigested RNA was then purified by phenol:chloroform extraction using TRI reagent® (Sigma Aldrich). The air-dried pellet containing undigested RNA was resuspended in nuclease-free water prior to RNA sequencing.

The air-dried pellet containing the extracted MNase-digested RNA was treated with 

Quality and adapter trimming was performed using TrimGalore v0.6.4

(http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) with default settings for automatic adapter detection. Adaptor trimmed and quality filtered reads were mapped to the human genome (GENCODE v35 primary assembly of GRCh38.p13) using STAR aligner (version 2.5.3a) [67] . Reads mapping to coding sequence (CDS) were counted to quantify transcripts capable of being translated into protein using featureCounts [68] . The Bioconductor package DESeq2 package in R (version 3.6.3) was used to test for differential expression between different experimental groups [69] .

Adaptor was trimmed from the reads using Cutadapt followed by filtering for quality across all genes. Differential expression analysis of translation efficiency was performed using Riborex package in R using DESeq2 as the modelling engine [21] . 

We are grateful for support from our colleagues at the Australian Centre for Disease Preparedness (https://www.grid.ac/institutes/grid.413322.5) for providing the facility used in the completion of this work. We also thank Shuning Shi, Kerri Bruce and Tamara Gough for maintenance of cell culture. Ondrej Hlinka in CSIRO Information, Management and Technology Business Unit for assistance in Sci-entific Computing. C   ZC3HAV1  IFNL2  HERC5  EIF2AK2  OAS3  RSAD2  OAS1  MX1  IRF1  TRIM22  DDX60  DDX58  IFIH1  IFNL1   IFI44L  IFIT5  IFIT1  DTX3L  IFNB1  OAS2  IFITM1  PARP9  OASL  IFNL3 

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses

A Novel Coronavirus from Patients with Pneumonia in China

Covid-19: Perspectives on Innate Immune Evasion. Front Immunol

Cytokine-induced sickness behavior: where do we stand? Brain Behav Immun

Immunopathogenesis of SARS-CoV-2-induced pneumonia: lessons from influenza virus infection. Inflamm Regen

In vivo antiviral host transcriptional response to SARS-CoV-2 by viral load, sex, and age

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Post-transcriptional regulation of gene expression in innate immunity

The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation

Multiorgan and Renal Tropism of SARS-CoV-2

Type I Interferon Susceptibility Distinguishes SARS-CoV-2 from SARS-CoV

Simple and inexpensive ribosome profiling analysis of mRNA translation

Translation inhibitors cause abnormalities in ribosome profiling experiments

GeneBase 1.1: a tool to summarize data from NCBI gene datasets and its application to an update of human gene statistics

Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling

Dynamics of ribosome scanning and recycling revealed by translation complex profiling

Translation of 5' leaders is pervasive in genes resistant to eIF2 repression

Widespread uncoupling between transcriptome and translatome variations after a stimulus in mammalian cells

NLRC5 negatively regulates the NF-kappaB and type I interferon signaling pathways

Extensive post-transcriptional buffering of gene expression in the response to severe oxidative stress in baker's yeast. Sci Rep

Riborex: fast and flexible identification of differential translation from Ribo-seq data

Database for mRNA half-life of 19 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse embryonic stem cells

Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity

Selective mRNA translation during eIF2 phosphorylation induces expression of IBTKalpha

A comprehensive catalog of predicted functional upstream open reading frames in humans

Type I interferons in infectious disease

Evasion of Type I Interferon by SARS-CoV-2. Cell Rep

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation

SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage

Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence

Dynamic innate immune responses of human bronchial epithelial cells to severe acute respiratory syndrome-associated coronavirus infection

Type I and Type III Interferons -Induction, Signaling, Evasion, and Application to Combat COVID-19

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice

Th1/17-Biased Inflammatory Environment Associated with COPD Alters the Response of Airway Epithelial Cells to Viral and Bacterial Stimuli

Fever and the thermal regulation of immunity: the immune system feels the heat

Frequency of coronavirus disease 2019 (COVID-19) symptoms in healthcare workers in a large health system

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Incubation periods of acute respiratory viral infections: a systematic review

Early IL-6 signalling promotes IL-27 dependent maturation of regulatory T cells in the lungs and resolution of viral immunopathology

Role of CCL5 (RANTES) in viral lung disease

Of Keeping and Tipping the Balance: Host Regulation and Viral Modulation of IRF3-Dependent IFNB1 Expression. Viruses

MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells

Zinc finger protein ZBTB20 promotes Toll-like receptor-triggered innate immune responses by repressing IkappaBalpha gene transcription

Systems biology approaches identify ATF3 as a negative regulator of Tolllike receptor 4

Dynamic competition between SARS-CoV-2 NSP1 and mRNA on the human ribosome inhibits translation initiation

IL-6 in inflammation, immunity, and disease

TLR4-induced NF-kappaB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a

Age-induced augmentation of p38 MAPK phosphorylation in mouse lung

Memory Th1/Th2 cell generation controlled by Schnurri-2

Early Growth Response Gene-1 Suppresses Foot-and-Mouth Disease Virus Replication by Enhancing Type I Interferon Pathway Signal Transduction

Regulation of IFN-lambda1 promoter activity (IFN-lambda1/IL-29) in human airway epithelial cells

PARP14 Controls the Nuclear Accumulation of a Subset of Type I IFN-Inducible Proteins

The coronavirus macrodomain is required to prevent PARP-mediated inhibition of virus replication and enhancement of IFN expression

Poly(ADP-ribose) polymerase-13 and RNA regulation in immunity and cancer

Post-transcriptional control during chronic inflammation and cancer: a focus on AU-rich elements

Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients

Interleukin-17 induces hyperresponsive interleukin-8 and interleukin-6 production to tumor necrosis factor-alpha in structural lung cells

A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation

Ribosome reinitiation can explain length-dependent translation of messenger RNA

Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes

Molecular biology of the cell

Redefining the Translational Status of 80S Monosomes

Functional Cyclization of Eukaryotic mRNAs

Regulation of translation initiation in eukaryotes: mechanisms and biological targets

Meta-analysis of host transcriptional responses to SARS-CoV-2 infection reveals their manifestation in human tumors

Promotion of Hendra virus replication by microRNA 146a

STAR: ultrafast universal RNA-seq aligner

featureCounts: an efficient general purpose program for assigning sequence reads to genomic features

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

GtRNAdb 2.0: an expanded database of transfer RNA genes identified in complete and draft genomes

The Sequence Alignment/Map format and SAMtools

BEDTools: a flexible suite of utilities for comparing genomic features